HOOKIPA Pharma Future Growth
Future criteria checks 2/6
HOOKIPA Pharma's earnings are forecast to decline at 8.4% per annum while its annual revenue is expected to grow at 25.8% per year. EPS is expected to grow by 2.9% per annum.
Key information
-8.4%
Earnings growth rate
2.9%
EPS growth rate
| Biotechs earnings growth | 24.6% |
| Revenue growth rate | 25.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 05 Jun 2024 |
Recent future growth updates
Recent updates
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Shares Fly 25% But Investors Aren't Buying For Growth
Apr 28
Analysts Just Made A Major Revision To Their HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenue Forecasts
Mar 24Need To Know: The Consensus Just Cut Its HOOKIPA Pharma Inc. (NASDAQ:HOOK) Estimates For 2023
Aug 11HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Just Slashed This Year's Revenue Estimates By 17%
May 16Is HOOKIPA Pharma (NASDAQ:HOOK) A Risky Investment?
Apr 26Need To Know: Analysts Are Much More Bullish On HOOKIPA Pharma Inc. (NASDAQ:HOOK) Revenues
Nov 19HOOKIPA wins FDA nod to start clinical studies for prostate cancer therapy
Jul 25Newsflash: HOOKIPA Pharma Inc. (NASDAQ:HOOK) Analysts Have Been Trimming Their Revenue Forecasts
May 18Hookipa: Speculative Biotech With Key Catalysts In 2022
Mar 29Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?
Oct 01Checking Back In On HOOKIPA Pharma
Jun 22Hookipa Pharma's HB-200 shows "positive" clinical efficacy in HPV16+ cancers
Jun 08Does HOOKIPA Pharma (NASDAQ:HOOK) Have A Healthy Balance Sheet?
Apr 19If You Had Bought HOOKIPA Pharma (NASDAQ:HOOK) Shares A Year Ago You'd Have Earned 64% Returns
Mar 15Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 6 | -131 | N/A | N/A | 3 |
| 12/31/2025 | 10 | -104 | N/A | N/A | 4 |
| 12/31/2024 | 54 | -48 | N/A | N/A | 4 |
| 3/31/2024 | 54 | -48 | -83 | -79 | N/A |
| 12/31/2023 | 20 | -82 | -62 | -58 | N/A |
| 9/30/2023 | 21 | -69 | -37 | -33 | N/A |
| 6/30/2023 | 16 | -68 | -28 | -26 | N/A |
| 3/31/2023 | 16 | -67 | -28 | -25 | N/A |
| 12/31/2022 | 14 | -65 | -25 | -20 | N/A |
| 9/30/2022 | 10 | -74 | -56 | -46 | N/A |
| 6/30/2022 | 12 | -76 | -59 | -48 | N/A |
| 3/31/2022 | 15 | -76 | -64 | -50 | N/A |
| 12/31/2021 | 18 | -76 | -79 | -66 | N/A |
| 9/30/2021 | 20 | -67 | -72 | -64 | N/A |
| 6/30/2021 | 20 | -60 | -63 | -57 | N/A |
| 3/31/2021 | 21 | -50 | -49 | -47 | N/A |
| 12/31/2020 | 20 | -44 | -42 | -39 | N/A |
| 9/30/2020 | 18 | -42 | -40 | -37 | N/A |
| 6/30/2020 | 16 | -40 | -39 | -36 | N/A |
| 3/31/2020 | 13 | -45 | -39 | -37 | N/A |
| 12/31/2019 | 12 | -43 | -44 | -42 | N/A |
| 9/30/2019 | 13 | -35 | -41 | -39 | N/A |
| 6/30/2019 | 13 | -27 | -38 | -37 | N/A |
| 3/31/2019 | 10 | -21 | -24 | -22 | N/A |
| 12/31/2018 | 8 | -16 | -17 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HOOK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: HOOK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: HOOK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: HOOK's revenue (25.8% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: HOOK's revenue (25.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HOOK's Return on Equity is forecast to be high in 3 years time